Get started
Author

Tetsuzo Tauchi

Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia
2006 · T Tauchi, K Shin-ya, et al. · Oncogene · 218
Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways
2003 · Tetsuzo Tauchi, Kazuo Shin-ya, et al. · Oncogene · 206
Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells
1993 · RA Mandanas, DS Leibowitz, et al. · Blood · 165
The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells.
1994 · T. Tauchi, G.S. Feng, et al. · Journal of Biological Chemistry · 145
Telomeres and telomerase in hematologic neoplasia
2002 · Junko H Ohyashiki, Goro Sashida, et al. · Oncogene · 143
Involvement of SH2-containing Phosphotyrosine Phosphatase Syp in Erythropoietin Receptor Signal Transduction Pathways
1995 · Tetsuzo Tauchi, Gen-Sheng Feng, et al. · Journal of Biological Chemistry · 140
PDF
The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
2009 · Junko H. Ohyashiki, Chiaki Kobayashi, et al. · Cancer Science · 131
PDF
Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
1994 · T Tauchi, H S Boswell, et al. · The Journal of Experimental Medicine · 128
A Member of Forkhead Transcription Factor FKHRL1 Is a Downstream Effector of STI571-induced Cell Cycle Arrest in BCR-ABL-expressing Cells
2003 · Norio Komatsu, Tomoko Watanabe, et al. · Journal of Biological Chemistry · 119
PDF
Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy
2003 · A Nakajima, T Tauchi, et al. · Leukemia · 103
Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study
2017 · The Japan Adult Leukemia Study Group, Naoto Takahashi, et al. · International Journal of Hematology · 98
Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis
1996 · T Tauchi, JE Damen, et al. · Blood · 95
SH2-containing phosphotyrosine phosphatase Syp is a target of p210bcr-abl tyrosine kinase.
1994 · T. Tauchi, G.S. Feng, et al. · Journal of Biological Chemistry · 84
PDF
Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
1995 · A Gotoh, K Miyazawa, et al. · PubMed · 81
Can Eradication Therapy for Helicobacter pylori Really Improve the Thrombocytopenia in Idiopathic Thrombocytopenic Purpura? Our Experience and a Literature Review
2003 · Keiko Ando, Takashi Shimamoto, et al. · International Journal of Hematology · 74
Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis
2002 · K Ohyashiki, Y Kuriyama, et al. · Leukemia · 72
Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1
2018 · Tsubasa Okano, Kohsuke Imai, et al. · Journal of Allergy and Clinical Immunology · 69
PDF
Molecular mechanisms of resistance of leukemia to imatinib mesylate
2003 · Tetsuzo Tauchi, Kazuma Ohyashiki · Leukemia Research · 63
A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.
2004 · M Sumi, T Tauchi, et al. · PubMed · 54
Increased natural killer cells and decreased CD3+CD8+CD62L+ T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib
2011 · Kazuma Ohyashiki, Sei‐ichiro Katagiri, et al. · British Journal of Haematology · 51
PDF
Glasdegib Plus Intensive/Nonintensive Chemotherapy in Untreated Acute Myeloid Leukemia: BRIGHT AML 1019 Phase III Trials
2019 · Jorge E Cortes, Hervé Dombret, et al. · Future Oncology · 49
PDF
Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells.
2002 · Tetsuzo Tauchi, Akihiro Nakajima, et al. · PubMed · 49
Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells
2002 · Masafumi Misawa, Tetsuzo Tauchi, et al. · International Journal of Oncology · 49
Establishment of a novel heterotransplantable acute lymphoblastic leukemia cell line with a t(17;19) chromosomal translocation the growth of which is inhibited by interleukin-3.
1991 · K Ohyashiki, H Fujieda, et al. · PubMed · 49
Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis
1991 · Kazuma Ohyashiki, Isayo Sasao, et al. · Cancer · 48
Works count: 337
Citation count: 4,326
H-index: 36
I10-index: 94
Year
Topic
Type